Emerging roles of interleukin and receptor activator nuclear factor ligand and osteoprotegerin levels in periodontal disease

An original research

https://doi.org/10.53730/ijhs.v6nS5.10638

Authors

  • Virendra Singh Prosthodontist, Ex- Professor, Department of Prosthodontics, Daswani Dental College and Research Centre, Kota, Rajasthan, India
  • Renu Orthodontist, Ex- Senior Resident, Pacific Institute of Medical Sciences, Udaipur, Rajasthan, India
  • Kalu Ram Kumawat PG Student, Department Of Paedodontics, RUHS College Of Dental Sciences, Jaipur, Rajasthan, India
  • Achira Bhaskar PG Student, Department Of Periodontology And Implantology, Darshan Dental College And Hospital, Udaipur, Rajasthan, India
  • Ramniwas Kumawat Oral Pathology, Assistant Professor, Government Medical College And Bangar Hospital, Pali, Rajasthan, India

Keywords:

Periodontitis, Interleukin-34, RANKL, OPG

Abstract

Introduction: Very few studies are done to evaluate IL-34 levels together with GCF RANKL and OPG levels in periodontitis patients before and after non-surgical periodontal treatment (NSPT). Materials and Methods: We included 150 patients to be equally divided to case and the controls. GCF and clinical periodontal recordings were investigated at the baseline and 6 weeks after non-surgical periodontal treatment NSPT. ELISA was used for quantifying of GCF IL-34, RANKL and OPG levels and their relative ratios were calculated. Results: Higher levels of GCF IL-34 and RANKL levels were found in the both the groups than in control group at baseline, whereas GCF OPG levels were statistically lower at baseline. GCF IL-34 and RANKL levels lowered in the 6th week after therapy in the both periodontitis groups, while the concentration OPG levels statistically amplified (P < 0.05). Significantly positive correlations among the IL-34 with RANKL, sampled-site clinical attachment level (CAL), and gingival index (GI), whereas negative correlation with OPG were reported (P < 0.05). Conclusions: Evaluation of the IL-34 levels together with RANKL/OPG ratio in GCF maybe valuable in identifying high risk individuals with periodontitis patients.

Downloads

Download data is not yet available.

References

A.S. Ertugrul, H. Sahin, A. Dikilitas, N. Alpaslan, A. Bozoglan, Comparison of CCL28, interleukin-8, interleukin-1beta and tumor necrosis factor-alpha in subjects with gingivitis, chronic periodontitis and generalized aggressive periodontitis, J. Periodontal Res. 48 (2013) 44–51.

B.F. Boyce, L. Xing, Functions of RANKL/RANK/OPG in bone modeling and remodeling, Arch. Biochem. Biophys. 473 (2008) 139–146.

G.S. Griffiths, Formation, collection and significance of gingival crevice fluid, Periodontol 2000 (31) (2003) 32–42.

L.S. Branco-de-Almeida, Y. Cruz-Almeida, Y. Gonzalez-Marrero, H. Huang, I. Aukhil, P. Harrison, S.M. Wallet, L.M. Shaddox, Local and plasma biomarker profiles in localized aggressive periodontitis, JDR Clin. Trans. Res. 2 (2017) 258–268.

N. Bostanci, B. Saygan, G. Emingil, G. Atilla, G.N. Belibasakis, Effect of periodontal treatment on receptor activator of NF-kappaB ligand and osteoprotegerin levels and relative ratio in gingival crevicular fluid, J. Clin. Periodontol. 38 (2011) 428–433.

P. Batra, S. Das, P. Patel, Comparative evaluation of Gingival Crevicular Fluid (GCF) levels of Interleukin-34 levels in periodontally healthy and in patients with chronic and aggressive periodontitis- A cross-sectional study, Saudi Dent. J. 31 (2019) 316–321.

Permana, A. T., Suroto, N. S., Parenrengi, M. A., Bajamal, A. H., Lestari, P., & Fauzi, A. A. (2022). Current update on stroke ischemic management: Stem cell as emerging therapy. International Journal of Health & Medical Sciences, 5(1), 122-128. https://doi.org/10.21744/ijhms.v5n1.1851

R. Clark, S. Zwicker, D. Bureik, G. Johannsen, E.A. Bostrom, Expression of colony- stimulating factor 1 and interleukin-34 in gingival tissue and gingival fibroblasts from periodontitis patients and controls, J. Periodontol. 91 (2020) 828–835.

S.B. Dogan, U. Balli, F.O. Dede, E. Sertoglu, K. Tazegul, Chemerin as a novel crevicular fluid marker of patients with periodontitis and type 2 diabetes mellitus, J. Periodontol. 87 (2016) 923–933.

S.J. Lin, Y.L. Chen, M.Y. Kuo, C.L. Li, H.K. Lu, Measurement of gp130 cytokines oncostatin M and IL-6 in gingival crevicular fluid of patients with chronic periodontitis, Cytokine 30 (2005) 160–167.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2022). Post-pandemic health and its sustainability: Educational situation. International Journal of Health Sciences, 6(1), i-v. https://doi.org/10.53730/ijhs.v6n1.5949

U. Balli, A. Aydogdu, F.O. Dede, C.C. Turer, B. Guven, Gingival crevicular fluid levels of sclerostin, osteoprotegerin, and receptor activator of nuclear factor- kappaB ligand in periodontitis, J. Periodontol. 86 (2015) 1396–1404.

U. Balli, A. Aydogdu, F.O. Dede, C.C. Turer, B. Guven, Gingival crevicular fluid levels of sclerostin, osteoprotegerin, and receptor activator of nuclear factorkappaB ligand in periodontitis, J. Periodontol. 86 (2015) 1396–1404.

X.E. Dereka, C.E. Markopoulou, G. Fanourakis, S. Tseleni-Balafouta, I.A. Vrotsos, RANKL and OPG mRNA level after non-surgical periodontal treatment, Inflammation 33 (2010) 200–206.

Published

15-08-2022

How to Cite

Singh, V., Renu, R., Kumawat, K. R., Bhaskar, A., & Kumawat, R. (2022). Emerging roles of interleukin and receptor activator nuclear factor ligand and osteoprotegerin levels in periodontal disease: An original research. International Journal of Health Sciences, 6(S5), 8614–8619. https://doi.org/10.53730/ijhs.v6nS5.10638

Issue

Section

Peer Review Articles

Most read articles by the same author(s)